Status:
TERMINATED
A Study of the Effects of a Novel Ovarian Stimulation Regimen on Embryo Aneuploidy Rates in In Vitro Fertilization (IVF)
Lead Sponsor:
Bart CJM Fauser
Conditions:
In Vitro Fertilization
Eligibility:
FEMALE
18-37 years
Phase:
PHASE4
Brief Summary
Background: By limiting the number of embryos transferred to the uterus to only a single embryo, the risk of multiple gestation can be reduced. In order to improve the effectiveness of single embryo ...
Eligibility Criteria
Inclusion
- Female age ≤ 37 years
- BMI 18-29 kg/m2
- Regular cycle (25-35 days)
- Standard indication for IVF
- No major uterine abnormalities
- Written informed consent
Exclusion
- Indication for IVF male factor with a total motile sperm count \< 20x106
- ICSI or andrological indication
- Known abnormal (male or female) karyotype
- Oocyte donation
- One previous IVF treatment not resulting in embryo transfer
- History of recurrent abortion
- Medical contra indication for pregnancy or IVF treatment
- Relevant systemic disease
- Active substance abuse
Key Trial Info
Start Date :
October 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 1 2011
Estimated Enrollment :
34 Patients enrolled
Trial Details
Trial ID
NCT00866008
Start Date
October 1 2008
End Date
January 1 2011
Last Update
July 22 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Medical Center Utrecht
Utrecht, Utrecht, Netherlands